Header cover image
  • Investing Ideas
  • /
  • Swedish Pharmaceuticals & Biotech Large Cap High Growth Potential

Swedish Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

Swedish Orphan Biovitrum

Market Cap: SEK 105.5b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

SOBI

SEK 307.20

7D

4.6%

1Y

6.4%